Announced Mon, 5 Oct, 2026 · 08:40 IST
Lord's Mark Industries gets MHRA registration for IVD portfolio
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+6.1%1-day move
₹79.40
prior close
₹80.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+2.6+2.4+2.8+2.5+6.1+6.1+1.3———————
Up moveDown movePending
AI summary
Lord's Mark Industries received MHRA registration for its IVD portfolio on Sept 24, 2026, covering haematological and clinical chemistry analysers, sample diluents and cleaning agents. The company plans to start UK commercial sales from Dec 2026, about 2 months ahead of schedule. A pathology laboratory launch is planned for Jan 2027. This follows the recent MHRA nod for its Renalyx haemodialysis system.
Likely market impact
Positive for stock: enables earlier UK sales entry, expanding into diagnostics beyond dialysis; supports international growth strategy.